Table 2.
Baseline Characteristics ‡ of All Randomized Trial Participants (N = 29).
| Age, years | 67.2 (11.6) |
| Women, % | 58.6 |
| Black, % | 69.0 |
| Medications for: | |
| Diabetes | 24.1% |
| Hypertension | 93.1% |
| Specific types of medications | |
| ACEI or ARB | 58.6% |
| K-sparing diuretic | 13.8% |
| K-wasting diuretic | 58.6% |
| Tacrolimus | 6.9% |
| Body Mass Index, kg/m2 | 31.4 (4.7) |
| Mean clinic BP, mm Hg | |
| SBP | 128.4 (13.0) |
| DBP | 71.5 (7.7) |
| Serum creatinine, mg/dL | 1.3 (0.2) |
| eGFR *, mL/min/1.73 m2 | 54.5 (11.7) |
‡ Mean (SD) for continuous variables, and % for categorical variables. * CKD-EPI Equation.